Gene · 64093
Papers1,848
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,848
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessing Aβ-independent effects of Module 42 on immune function in vitro. | Alzheimers Dement | 2026 | 41738163 | PubTator, text mining | PubMed |
| Serum proteomic characterization of stump-tailed macaques (Macaca arctoides) with neutralizing antibodies against Dengue virus in Thailand. | PLoS One | 2026 | 41729959 | PubTator, text mining | PubMed |
| Unbiased cleavage site prediction uncovers viral antagonism of host innate immunity by SARS-CoV-2 3C-like protease. | JCI Insight | 2026 | 41729072 | PubTator, text mining | PubMed |
| Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond. | Curr Opin Neurol | 2026 | 41725559 | PubTator, text mining | PubMed |
| LICHEN enables light-chain immunoglobulin sequence generation conditioned on the heavy chain and experimental needs. | Commun Biol | 2026 | 41723256 | PubTator, text mining | PubMed |
| O-Acetyl-Serine Supplementation Enhances Insulin Secretion and Improves Postprandial Glycaemia in Lean and Prediabetic Mice. | FASEB J | 2026 | 41718459 | PubTator, text mining | PubMed |
| The Runx2-SMOC axis in skeletal development: Expanding roles of Smoc1 and Smoc2 in development and disease. | J Oral Biosci | 2026 | 41714037 | PubTator, text mining | PubMed |
| Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns. | Alzheimers Dement | 2026 | 41650025 | PubTator, text mining | PubMed |
| Virus-like particles based on plant viruses and bacteriophages: emerging strategies for the delivery of nucleic acid therapeutics. | Chem Sci | 2026 | 41647042 | PubTator, text mining | PubMed |
| Intrinsic tumor factors and extrinsic environmental and social exposures contribute to endometrial cancer recurrence patterns. | Res Sq | 2026 | 41646408 | PubTator, text mining | PubMed |
| Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging. | Alzheimers Dement | 2026 | 41612914 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of the Antiviral Responses in Ovine Type II Alveolar Epithelial Cells During Early Stage of Bluetongue Virus Infection. | Animals (Basel) | 2026 | 41594433 | PubTator, text mining | PubMed |
| Comprehensive profiling of Aβ40 and Aβ42 fibril-interacting proteins reveals PRKCG as a drug-targetable regulator of amyloidogenesis in Alzheimer's disease. | Alzheimers Dement | 2026 | 41572619 | PubTator, text mining | PubMed |
| The shared biomarkers and molecular mechanisms of systemic lupus erythematosus and type 2 diabetes. | PLoS One | 2026 | 41569989 | PubTator, text mining | PubMed |
| Inhibition of RNase L enhances the expression efficiency of mRNA-LNPs. | Mol Immunol | 2026 | 41564652 | PubTator, text mining | PubMed |
Efficacy and safety of aerosol inhalation of recombinant human interferon-α2b injection in children hospitalized with human adenovirus pneumonia: a prospective, multicenter, randomized, controlled trial in China. | Int J Surg | 2026 | 41556198 | PubTator, text mining | PubMed |
| The OAS-RNase L pathway: Insights from experiments of nature. | Sci Immunol | 2026 | 41512080 | PubTator, text mining | PubMed |
| Human alphacoronavirus replication and innate immune induction in airway culture systems. | mBio | 2026 | 41369222 | PubTator, text mining | PubMed |
Molecular characterization of the effects of essential oils on mRNA gene expression related to proinflammatory and antiviral pathways, virus load, and antibody production in chickens vaccinated against Newcastle disease virus, infectious bursal disease virus, and infectious bronchitis virus. | Poult Sci | 2026 | 41352186 | PubTator, text mining | PubMed |
| mRNA vaccines transform personalized lung cancer treatment. | Front Immunol | 2025 | 41766818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64093/papers?page=3